TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Conditions: Crohn Disease; Infliximab; Perianal Fistula Due to Crohn's Disease; Therapeutic Drug Monitoring; Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score Interventions: Drug: TDM-based infliximab intravenous therapy; Drug: Standard infliximab intravenous therapy Sponsor: Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Conditions: Crohn Disease; Infliximab; Perianal Fistula Due to Crohn ' s Disease; Therapeutic Drug Monitoring; Magnetic Resonance Novel Index for Fistula Imaging in Crohn ' s Disease Score Interventions: Drug: TDM-based infliximab intravenous therapy; Drug: Standard infliximab intravenous therapy Sponsors: Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Condition: Crohn's Disease Interventions: Drug: Vedolizumab; Drug: Adalimumab; Drug: Ustekinumab Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials